- Home
- CMCL vs FENC Comparison
CMCL vs FENC Comparison
Compare CMCL & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMCL
- FENC
- Stock Information
- Founded
- CMCL 1992
- FENC 1996
- Country
- CMCL Jersey
- FENC United States
- Employees
- CMCL N/A
- FENC N/A
- Industry
- CMCL Precious Metals
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMCL Basic Materials
- FENC Health Care
- Exchange
- CMCL Nasdaq
- FENC Nasdaq
- Market Cap
- CMCL 321.6M
- FENC 222.9M
- IPO Year
- CMCL N/A
- FENC 2001
- Fundamental
- Price
- CMCL $20.89
- FENC $9.08
- Analyst Decision
- CMCL Strong Buy
- FENC Strong Buy
- Analyst Count
- CMCL 1
- FENC 2
- Target Price
- CMCL $21.00
- FENC $13.00
- AVG Volume (30 Days)
- CMCL 157.0K
- FENC 76.7K
- Earning Date
- CMCL 08-11-2025
- FENC 08-12-2025
- Dividend Yield
- CMCL 2.68%
- FENC N/A
- EPS Growth
- CMCL N/A
- FENC N/A
- EPS
- CMCL 1.28
- FENC N/A
- Revenue
- CMCL $190,568,000.00
- FENC $30,912,000.00
- Revenue This Year
- CMCL $20.99
- FENC $0.85
- Revenue Next Year
- CMCL $0.56
- FENC $55.16
- P/E Ratio
- CMCL $15.83
- FENC N/A
- Revenue Growth
- CMCL 29.36
- FENC N/A
- 52 Week Low
- CMCL $8.81
- FENC $3.96
- 52 Week High
- CMCL $22.20
- FENC $9.27
- Technical
- Relative Strength Index (RSI)
- CMCL 60.88
- FENC 64.16
- Support Level
- CMCL $20.14
- FENC $7.94
- Resistance Level
- CMCL $22.20
- FENC $8.92
- Average True Range (ATR)
- CMCL 0.88
- FENC 0.40
- MACD
- CMCL -0.02
- FENC 0.02
- Stochastic Oscillator
- CMCL 62.89
- FENC 97.12
About CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.